MEDICYTE

USPTO USPTO 2008 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark MEDICYTE was filed as Word mark on 03/17/2008 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 06/05/2012. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: August 14, 2019

Trademark form Word mark
File reference 77423742
Register number 4152087
Application date March 17, 2008
Publication date April 13, 2010
Entry date June 5, 2012

Trademark owner

Im Neuenheimer Feld 581
69120 Heidelberg
DE

Trademark representatives

goods and services

1 Proteins, nucleic acids, genes, and cells for medical research purposes
5 Pharmaceutical and veterinary products for the treatment of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy; drugs for the treatment of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy in humans; protein supplements; proteins, nucleic acids, genes, and cells for medical diagnostics and treatment; medical, biological, chemical, biotechnological, and gene-technological products and preparations for medical use for the treatment of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy; diagnostic preparations for medical and veterinary use
10 Diagnostic devices for medical and veterinary use, namely, for diagnosing cardiovascular disease, stroke, cancer, tumors, diseases of the pancreas, kidney and liver and neurodegenerative diseases
35 Administrative processing of purchase orders in the field of chemistry, biotechnology, diagnostics, and gene-therapy; administrative processing of purchase orders in the field of pharmaceuticals and medicines, medicines for humans, veterinary medicines, and gene-therapy; business consultation services in the field of medicine, all such services limited to primary cell production technology
42 Scientific services for pharmaceutical biotechnological, diagnostic, analytical, medical, or gene-technological laboratories, industrial facilities, research and development facilities in the field of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy; scientific consulting services in the field of chemistry, biotechnology, diagnostics, and gene-technology, namely, consulting services provided via the Internet; mission-oriented research in the field of chemistry, pharmacy, biotechnology, diagnostics, gene-technology, and medicine; services of a chemical laboratory; conducting of chemical examinations; services of a medical laboratory; medical laboratory services in the nature of conducting medical and clinical trials
44 Medical consultation; consulting services in the field of medicine, namely, human medicine, veterinary medicine, pharmacy, and gene-therapy in the nature of cell therapy; medical consultation services provided via the Internet; medical care; medical information services, namely, laboratory services that report results directly to the patient

ID: 1377423742